The company held a safety management video conference to implement operation safety risk assessment and control
Release time:
2022-04-06
News from our newspaper 3# March 25 , in order to implement the work of safety risk assessment and control, the group company held a safety management video conference to interpret and publicize in detail the relevant requirements of the safety risk prevention and control superior enterprise appraisal activities starting from July 3# and the newly issued "Work Safety Risk Assessment and Control System" to deploy the next stage of safety work.
In the first quarter of this year, the incidence of safety accidents in the company's subsidiaries has increased, and the pressure on safety management has increased. In view of this situation, the group company carried out the evaluation activities of the winning enterprises in safety risk prevention and control, convened the main responsible persons of each enterprise to hold a meeting, and reported the recent production safety accidents. Li Xiaoyin, director of the company's safety management office, explained the "Operation Safety Risk Assessment and Control System". Yu Jianhong, general manager of the group company, and Chen Tianci, chairman of the board of supervisors, attended the meeting and put forward requirements for safety management.Chen Tianci said at the meeting that safety risk assessment and control is the focus of the company's safety production management in the past two years, and the evaluation activities are aimed at urging all units to establish and improve the risk prevention and control system. The person in charge of safety management of each unit should strengthen the study and implementation of the Operation Safety Risk Assessment and Control System, seriously carry out the work of operation safety risk assessment and control, and focus on the investigation and management of potential safety hazards, strengthen the safety training for employees in production positions, and focus on the publicity and prevention of typical violations, so that everyone can memorize, identify and correct them, so as to achieve less violation, no violation. In his speech at the meeting, Yu Jianhong pointed out that in the new era, the requirements for production safety are higher, the punishment is stricter, and the consequences of safety accidents to enterprises are more serious. The management teams at all levels of the company have always attached great importance to safety management and have been making unremitting efforts to improve the level of safety management. In the future work, the safety management personnel of each enterprise should strive to improve their own quality, deeply understand the process of each production link, be familiar with the way of operation and industry, and identify the source of risk; comprehensively improve the safety management requirements, improve the safety protection of on-site facilities and equipment, and increase safety publicity and training, so that all employees can fully realize the seriousness of safety accidents and the serious consequences that may lead, reach safety accident
"dare not commit, will not commit, cannot commit".
Yu Jianhong emphasized that safety management is a technology and a system engineering with strong professionalism. Responsible persons at all levels of safety management should innovate their understanding, gradually improve safety management methods, change from post-punishment to prior control, extend from result-oriented to process-oriented, and pay attention to the control of the whole process. Safety management should run through all aspects of project planning, design, site selection, installation, equipment operation, maintenance, repair, production, storage, sales, etc., and "whether an accident occurs" should not be the only focus of safety assessment, but should pay equal attention to "whether there are potential safety hazards" and "whether there are risk control plans" to truly prevent problems before they occur. (Reporter Chen Shengmu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page